Jori, M C <br/><br/>
Clinical experience with cabergoline, a new ergoline derivative, in the treatment of Parkinson's disease.  [electronic resource] 

 -  Advances in neurology  1990 
 - 539-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0091-3952 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Aged<br/>Antiparkinson Agents<br/>Cabergoline<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Ergolines--administration & dosage<br/>Female<br/>Humans<br/>Male<br/>Neurologic Examination<br/>Parkinson Disease--drug therapy